Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Quinolones Market Value Expansion And Long-Term Growth Outlook
The quinolones market has experienced consistent expansion over the past few years. Projections indicate an increase from $51.89 billion in 2025 to $54.48 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.0%. This historical growth has been driven by factors such as a rising incidence of bacterial infections, a higher number of hospital admissions, a strong need for broad-spectrum antibiotics, the expansion of retail pharmacy networks, and government programs aimed at controlling infectious diseases.
The quinolones market is projected to experience significant growth over the coming years, reaching a value of $66.44 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.1%. This anticipated expansion during the forecast period is fueled by progress in precision medicine, the introduction of innovative quinolone formulations, the growth of online pharmaceutical platforms, heightened awareness surrounding antimicrobial stewardship, and the increased adoption of digital health monitoring technologies. Key developments shaping this period encompass strategies for managing rising antibiotic resistance, the broader availability of generic medications, customized therapeutic approaches, the expansion of outpatient and home-based healthcare services, and heightened investment in research and development for next-generation quinolones.
Download A Free Sample Report For Comprehensive Market Insights:
Quinolones Market Growth Momentum: Which Factors Are Influencing Demand?
The rising threat of antimicrobial resistance is anticipated to drive expansion in the quinolones market in the coming period. Antimicrobial resistance (AMR) is defined as the capacity of microorganisms—including bacteria, viruses, parasites, and fungi—to withstand the effects of antimicrobial medications. Quinolones offer a wide-ranging activity, which allows them to be effective against numerous bacterial strains. They are prescribed for particular infection types due to their ability to penetrate diverse tissues, making them a favored option when alternatives are scarce. For example, in October 2025, the World Health Organization, an intergovernmental body based in the US, released a comprehensive global analysis that examined antibiotic resistance prevalence and trends. This study drew on data from over 23 million confirmed cases of bloodstream, urinary tract, and gastrointestinal infections, as well as urogenital gonorrhea, with findings based on reports submitted by 104 countries in 2023. Consequently, the growing danger of antimicrobial resistance is fueling the growth of the quinolones market.
Quinolones Market Segmentation: How Is The Market Structured Across Key Categories?
The quinolones market covered in this report is segmented –
1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Quinolones Market Trends Reshaping Industry Growth
Key players in the quinolones sector are increasingly prioritizing product advancements, specifically by developing fluoroquinolone antibiotic eye drops, as a strategy to boost their revenue streams. These eye drops represent a specific category of antibiotics formulated to combat bacterial infections affecting the eyes. A notable example occurred in July 2023, when Harrow Health Inc., a pharmaceutical firm based in the United States, introduced Vigamox to the market. This solution is isotonic, possessing an osmolality of approximately 290 mOsm/kg, and it provides 5.45 mg of moxifloxacin hydrochloride, which corresponds to 5 mg of moxifloxacin base. The product is supplied in a 3-milliliter bottle and is presented as a sterile ophthalmic solution within a dispensing system composed of a natural low-density polyethylene bottle, a dispensing plug, and a tan polypropylene closure. Vigamox is indicated for use in preventing eye infections both prior to and following surgical procedures.
Quinolones Market Competitive Landscape And Leading Companies
Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.
Access The Complete Quinolones Market Report:
Quinolones Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model